StockData

Autonomix Medical vs Neuroone Medical Technologies

AMIX and NMTC side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AMIX and NMTC compare

Neuroone Medical Technologies is the larger company, worth 5.1 times as much as Autonomix Medical ($6.8M against $1.3M).

Neuroone Medical Technologies scores higher on the StockData Score (11 against 6 for Autonomix Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAMIXNMTC
Size and price
Market cap$1.3M$6.8M
Share price$1.37$0.745
Change, 1 year−92.3%−83.1%
Change, 5 years–−94.9%
Beta (5Y)1.560.71
Employees1118
StockData Score
Total score611 (better)
Valuation score13 (better)
Growth score02 (better)
Performance score01 (better)
Health score55
Dividend score00
Valuation
P/S–0.7×
P/B0.2× (better)1.8×
FCF yield–−106%
Fair value–$3.60
Margin of safety–79.3%
Growth
Revenue growth (TTM)–42.8%
Profitability
Gross margin–55.6%
Operating margin–−83.4%
Net margin–−78.6%
FCF margin–−75.6%
Return on equity−176%−125% (better)
Return on invested capital–−672%
Financial health
Debt / equity0.000.00
Current ratio6.52 (better)2.84
Altman Z-score−15.66 (better)−19.38
Piotroski F-score26 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions5.2%22.7%
Held by insiders7.8%85.4%
Insider net buying, 12 months–$682K
Short interest, % of float6.2%15.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.